These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16140934)

  • 1. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
    Schwartz SA; Weil RJ; Thompson RC; Shyr Y; Moore JH; Toms SA; Johnson MD; Caprioli RM
    Cancer Res; 2005 Sep; 65(17):7674-81. PubMed ID: 16140934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging mass spectrometry: principles and potentials.
    Chaurand P; Schwartz SA; Reyzer ML; Caprioli RM
    Toxicol Pathol; 2005; 33(1):92-101. PubMed ID: 15805060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.
    Le Rhun E; Duhamel M; Wisztorski M; Gimeno JP; Zairi F; Escande F; Reyns N; Kobeissy F; Maurage CA; Salzet M; Fournier I
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):875-890. PubMed ID: 27890679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
    Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin nitration in human gliomas.
    Fiore G; Di Cristo C; Monti G; Amoresano A; Columbano L; Pucci P; Cioffi FA; Di Cosmo A; Palumbo A; d'Ischia M
    Neurosci Lett; 2006 Feb; 394(1):57-62. PubMed ID: 16257120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification and survival prediction in human gliomas based on proteome analysis.
    Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
    Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
    Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
    Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical exploration of energetic metabolism and oxidative stress in low grade gliomas: central and peripheral tumor tissue analysis].
    Lamari F; La Schiazza R; Guillevin R; Hainque B; Foglietti MJ; Beaudeux JL; Bernard M
    Ann Biol Clin (Paris); 2008; 66(2):143-50. PubMed ID: 18390424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis.
    Krafft C; Thümmler K; Sobottka SB; Schackert G; Salzer R
    Biopolymers; 2006 Jul; 82(4):301-5. PubMed ID: 16506167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosphingolipid component profiles or human gliomas--correlation to survival time and histopathological malignancy grading.
    Becker R; Rohlfs J; Jennemann R; Wiegandt H; Mennel HD; Bauer BL
    Clin Neuropathol; 2000; 19(3):119-25. PubMed ID: 14606584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the raw serum peptidomic pattern in glioma patients.
    Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
    Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study.
    Remmerbach TW; Maurer K; Janke S; Schellenberger W; Eschrich K; Bertolini J; Hofmann H; Rupf S
    Oral Oncol; 2011 Apr; 47(4):278-81. PubMed ID: 21354855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.